Project Grant K22AI174008
Award Date
5/2/25
Completion Date
4/30/27
Dollars Obligated
$162K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $3,351,260 to Vanderbilt University Medical Center to mechanistically define how oxidative stress and mitochondrial dysfunction can promote inflammatory cell death modalities during Mycobacterium tuberculosis (MTB) infection. The overarching goal is to better understand how certain genetic and environmental...
This federal Project Grant award of $784,217.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to characterize how cellular death programs contribute to both protective and injurious inflammation during bacterial infections. The research will utilize human cells, murine genetics, and knockdown/knockout strategies to understand how components of cell death signaling, such as...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $176,537 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the CAL Poly Pomona Foundation Inc. The project aims to uncover the innate immune responses and mechanisms involved in how neutrophils use reactive oxygen species (ROS) to control acute Toxoplasma gondii infection. Specifically, the project will: 1) Determine the cellular events required to induce ROS in T....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund a $239,348 research project to investigate a newly identified population of CD1a-restricted T cells that respond to the lipid antigen phosphatidylglycerol (PG). The key objectives of this research are to determine the conditions under which mitochondrial PG becomes visible to these T cells, compare the antigenicity of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $870,531 in funding to the University of Notre Dame to conduct research focused on identifying the mycobacterial genes that control bacteriolysis, or bacterial cell lysis, within the macrophage cytoplasm. The research objectives are to determine if known virulence pathways protect mycobacteria from bacteriolysis in the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $715,216 to Louisiana State University (LSU) over a 5-year period from July 2024 to May 2029. The funding will support research to understand the role of the transcription factor Nrf2 in enhancing host immune defenses and reducing tissue damage during Carbapenem-Resistant Klebsiella pneumoniae (CRKP) infections....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is focused on studying the innate immune responses of alveolar macrophages to Mycobacterium tuberculosis (MTB) infection. The $447,009 award, with a performance period from August 15, 2024 to June 30, 2029, aims to evaluate mechanisms that regulate alveolar macrophage sensing and responses to MTB. The research will categorize...
This $840,880 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to develop and refine in vitro Precision Cut Lung Slice (PCLS) models for studying the fungus Pneumocystis, a leading cause of fungal pneumonia. The goal is to optimize this PCLS model to enable improved understanding of the Pneumocystis life cycle, mechanisms of fungal attachment, and in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,063,350 to Tulane University to investigate the role of recent thymic emigrants (RTEs) in reducing influenza-induced pulmonary inflammation. The primary objective is to demonstrate the importance of CD4+ RTEs in an infectious inflammatory setting and identify how they can reduce severe, life-threatening...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), totals $2,913,004.00 and will be implemented from June 1, 2024 to April 30, 2029. The award supports research to identify the mechanisms by which Programmed Death Ligand 1 (PD-L1) reverse or intracellular signaling acts as an immune regulator in the liver during acute infection, chronic infection, and chronic disease. The...